Once Daily Versus Three Times Daily Mesalazine in Ulcerative Colitis by Hiba Sal
76,65 €
The study was conducted for a period of 18 months from February 2014 to July 2015. This study has demonstrated a clinical remission of 61.3% patients in the O.D group and 62.1% in TID. Endoscopic remission was achieved in 71% of patients in O.D group compared to 62.1% in the TID group at the end of 8th week and a Histological remission of 74.2% patients in OD group and 58.6 in the TID group.Patients in O.D group had a significant relief of abdominal pain compared to the TID group (p 0.020).
Jetzt bei Ebay:
![Produktbild - Management and Future Prospects of Ulcerative Colitis by Eldon Miller [Hardback]](https://i.ebayimg.com/thumbs/images/g/cX4AAOSwcndnWLTF/s-l140.jpg)
![Produktbild - Ulcerative Colitis: Genetics to Complexities by Eldon Miller [Hardback]](https://i.ebayimg.com/thumbs/images/g/ECQAAOSwoM9nWLTO/s-l140.jpg)
![Produktbild - Questions & Answers About Ulcerative Colitis by Francis A. Farraye [Paperback]](https://i.ebayimg.com/thumbs/images/g/qkgAAOSwzT5nbIW6/s-l140.jpg)
